BRPI0821105A2 - ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular - Google Patents
ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascularInfo
- Publication number
- BRPI0821105A2 BRPI0821105A2 BRPI0821105A BRPI0821105A BRPI0821105A2 BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2 BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2
- Authority
- BR
- Brazil
- Prior art keywords
- diseases
- therapeutic
- diagnostic tools
- vascular function
- alter vascular
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000004218 vascular function Effects 0.000 title 1
- 229920002306 Glycocalyx Polymers 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 210000004517 glycocalyx Anatomy 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000006438 vascular health Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/50—Lipopolysaccharides; LPS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/328—Vasculitis, i.e. inflammation of blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122043 | 2007-11-30 | ||
| PCT/EP2008/066524 WO2009068685A1 (en) | 2007-11-30 | 2008-12-01 | Diagnostic and therapeutic tools for diseases altering vascular function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0821105A2 true BRPI0821105A2 (pt) | 2015-10-06 |
Family
ID=39247715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0821105A BRPI0821105A2 (pt) | 2007-11-30 | 2008-12-01 | ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8759095B2 (pt) |
| EP (1) | EP2215480B1 (pt) |
| JP (1) | JP5597543B2 (pt) |
| CN (1) | CN101918845B (pt) |
| AT (1) | ATE554396T1 (pt) |
| BR (1) | BRPI0821105A2 (pt) |
| CA (1) | CA2706307C (pt) |
| DK (1) | DK2215480T3 (pt) |
| ES (1) | ES2386231T3 (pt) |
| PL (1) | PL2215480T3 (pt) |
| PT (1) | PT2215480E (pt) |
| WO (1) | WO2009068685A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759095B2 (en) | 2007-11-30 | 2014-06-24 | Universiteit Maastricht | Diagnostic and therapeutic tools for diseases altering vascular function |
| CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| US10070796B2 (en) | 2015-02-04 | 2018-09-11 | General Electric Company | Systems and methods for quantitative microcirculation state monitoring |
| CA3020277C (en) | 2015-04-08 | 2026-07-21 | Microvascular Health Solutions, LLC | Synergistic glycocalyx treatment compositions and methods |
| WO2016176089A1 (en) | 2015-04-29 | 2016-11-03 | Kardiatonos, Inc. | Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage |
| US10507253B2 (en) | 2016-03-17 | 2019-12-17 | Paul C. Lee | Nanoparticle probes and methods of making and use thereof |
| US10507252B2 (en) | 2016-03-17 | 2019-12-17 | Paul C. Lee | Nanoparticle probes and methods of making and use thereof |
| WO2018208846A1 (en) * | 2017-05-08 | 2018-11-15 | Microvascular Health Solutions, LLC | Compositions, systems, and methods for assessing and improving vascular health and treatments involving the same |
| CN107271348B (zh) * | 2017-07-06 | 2019-11-15 | 苏州大学 | 一种医用人造管道渗透性能测试系统及其使用方法 |
| US11994519B2 (en) * | 2017-12-13 | 2024-05-28 | Glx Analytix Aps | Biomarkers for multiple sclerosis |
| CN108681510A (zh) * | 2018-05-21 | 2018-10-19 | 迈克医疗电子有限公司 | 数据处理方法及装置 |
| EP3623816A1 (en) | 2018-09-12 | 2020-03-18 | GLX Analytix ApS | Glx-derived molecule detection |
| FI3666883T3 (fi) * | 2018-12-12 | 2025-05-13 | Zhongke Xinray Suzhou Biological Tech Co Limited | Menetelmä endoteelin glykokalyksiin liittyviä sairauksia vastaan ennaltaehkäisevän ja terapeuttisen vaikutuksen omaavien yhdisteiden seulomiseksi |
| WO2021062298A1 (en) | 2019-09-27 | 2021-04-01 | Arterez, Inc. | Biomarker panel targeted to diseases due to multifactorial ontology of glycocalyx disruption |
| US11852577B2 (en) * | 2021-09-29 | 2023-12-26 | Orange Biomed Ltd., Co. | Apparatus for measuring properties of particles in a solution and related methods |
| EP4630783A1 (en) | 2022-12-09 | 2025-10-15 | Orange Biomed Co., Ltd. | Sample-testing system for measuring properties of red blood cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| JP3566756B2 (ja) * | 1993-09-03 | 2004-09-15 | 謙 石原 | 非侵襲血液分析装置とその方法 |
| JP2003510112A (ja) | 1999-09-23 | 2003-03-18 | ジー．ナドウ リチャード | 直交偏光スペクトルイメージングの医学的応用 |
| EP1501565B1 (de) * | 2002-05-09 | 2006-11-02 | Hemoteq GmbH | Verbindungen und verfahren zur hemokompatiblen beschichtung von oberflächen |
| US7497940B2 (en) | 2003-09-02 | 2009-03-03 | Koji Sode | Glucose sensor and glucose level measuring apparatus |
| EP1751509A1 (en) | 2004-05-14 | 2007-02-14 | Koninklijke Philips Electronics N.V. | Fiber optic probe |
| JP2007054483A (ja) | 2005-08-26 | 2007-03-08 | Olympus Corp | 装着型顕微鏡システム |
| WO2007075388A2 (en) | 2005-12-15 | 2007-07-05 | X-Cell Medical Incorporated | Methods of locally treating and preventing cardiac disorders |
| US8759095B2 (en) | 2007-11-30 | 2014-06-24 | Universiteit Maastricht | Diagnostic and therapeutic tools for diseases altering vascular function |
-
2008
- 2008-12-01 US US12/734,876 patent/US8759095B2/en active Active
- 2008-12-01 PL PL08855400T patent/PL2215480T3/pl unknown
- 2008-12-01 PT PT08855400T patent/PT2215480E/pt unknown
- 2008-12-01 JP JP2010535403A patent/JP5597543B2/ja active Active
- 2008-12-01 AT AT08855400T patent/ATE554396T1/de active
- 2008-12-01 BR BRPI0821105A patent/BRPI0821105A2/pt not_active Application Discontinuation
- 2008-12-01 DK DK08855400.1T patent/DK2215480T3/da active
- 2008-12-01 WO PCT/EP2008/066524 patent/WO2009068685A1/en not_active Ceased
- 2008-12-01 EP EP08855400A patent/EP2215480B1/en active Active
- 2008-12-01 CA CA2706307A patent/CA2706307C/en active Active
- 2008-12-01 CN CN200880118620.8A patent/CN101918845B/zh active Active
- 2008-12-01 ES ES08855400T patent/ES2386231T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100304424A1 (en) | 2010-12-02 |
| DK2215480T3 (da) | 2012-07-30 |
| US8759095B2 (en) | 2014-06-24 |
| EP2215480B1 (en) | 2012-04-18 |
| CA2706307A1 (en) | 2009-06-04 |
| JP2011507560A (ja) | 2011-03-10 |
| CN101918845A (zh) | 2010-12-15 |
| EP2215480A1 (en) | 2010-08-11 |
| JP5597543B2 (ja) | 2014-10-01 |
| WO2009068685A1 (en) | 2009-06-04 |
| ATE554396T1 (de) | 2012-05-15 |
| PL2215480T3 (pl) | 2012-09-28 |
| CA2706307C (en) | 2017-01-17 |
| CN101918845B (zh) | 2014-01-29 |
| PT2215480E (pt) | 2012-07-18 |
| ES2386231T3 (es) | 2012-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE554396T1 (de) | Diagnose- und therapiewerkzeuge für krankheiten, die die gefässfunktion verändern | |
| CY1121327T1 (el) | Τροποποιημενα αντισωματα anti-il-23p19 | |
| ECSP10010344A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| CO6450665A2 (es) | Anticuerpos anti-fgfr3 y métodos que los utilizan | |
| PA8774501A1 (es) | Nueva sales y sus usos | |
| MX2013001362A (es) | Inmunoglubinas de dominio variable doble y usos de las mismas. | |
| UY31563A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| MA32934B1 (fr) | Combinaisons inhibitrices hsp90 | |
| ECSP10010580A (es) | Inmunoglobulinas duales de dominio variable y sus aplicaciones | |
| EA201101520A1 (ru) | Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
| UY31562A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| BRPI0923507A2 (pt) | motor e dispositivo elétrico que usa o mesmo. | |
| GT200800123A (es) | Compuestos mimeticos de lisina modificados | |
| ES2352576T8 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana. | |
| BRPI1008692A2 (pt) | moléculas de anticorpos tendo especificidade para ox40 humano. | |
| AR061757A1 (es) | Lentes oftalmologicas multifocales de transicion gradual | |
| ECSP11011496A (es) | Inmunoglobulinas de dominio variable dual y usos de las mismas | |
| BRPI0810185A2 (pt) | Regulador de fluído e aparelho. | |
| BRPI1010887A2 (pt) | derivados de triazina e suas aplicações terapêuticas. | |
| BRPI0719904A2 (pt) | Aço inoxidável martensítico | |
| UY32979A (es) | Inmunoglobulinas con dominio variable dual y usos de las mismas | |
| BR112014008224A2 (pt) | derivados do fator vii e viia de coagulação sanguínea, conjugados e complexos que incluem o mesmo e utilização do mesmo | |
| CY1116802T1 (el) | Ετεροκυκλικες ενωσεις | |
| BRPI0906608A2 (pt) | Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial. | |
| FR2924118B1 (fr) | Fragments d'anticorps inhibiteurs de la proteine nef du vih. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |